Paediatric acquired inflammatory demyelinating disorders of the central nervous system

Our understanding of paediatric acquired inflammatory demyelinating diseases is continually evolving. By integrating extensive clinical and paraclinical data, we can refine diagnostic accuracy using epidemiological information, clinical presentations, specific antibodies, and radiological abnormalities. Tailored management approaches can then be implemented based on the most congruent clinical picture. The availability of international collaborative research and standardised group protocols facilitates the selection of optimal immunosuppressive drug regimens, ensuring effective management of the disease and its comorbidities. Acute disseminated encephalomyelitis, acute optic neuritis, and acute transverse myelitis are observed in both paediatric and adult populations. However, there are notable differences in their clinical and radiological phenotypes, treatment considerations, and prognoses in the younger group. Understanding these distinctions is crucial for developing age-appropriate diagnostic and therapeutic strategies and predicting long-term outcomes in affected individuals. This article integrates the latest advancements and data to synthesize and critique the literature on acute acquired demyelinating disorders in children.